Skip to Content
Merck
  • Fragment-based discovery of selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase PtpA.

Fragment-based discovery of selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase PtpA.

Bioorganic & medicinal chemistry letters (2009-11-06)
Katherine A Rawls, P Therese Lang, Jun Takeuchi, Shinichi Imamura, Tyler D Baguley, Christoph Grundner, Tom Alber, Jonathan A Ellman
ABSTRACT

The development of low muM inhibitors of the Mycobacterium tuberculosis phosphatase PtpA is reported. The most potent of these inhibitors (K(i)=1.4+/-0.3 microM) was found to be selective when tested against a panel of human tyrosine and dual-specificity phosphatases (11-fold vs the highly homologous HCPtpA, and >70-fold vs all others tested). Modeling the inhibitor-PtpA complexes explained the structure-activity relationships observed in vitro and revealed further possibilities for compound development.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Benzanilide, 98%